Bioanalytical Systems Inc. (BASI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.11-0.09 (-7.50%)
At close: 4:00 PM EDT
People also watch:
BDMSBBGIBNSOAHPICASM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open1.19
Prev Close1.20
Bid1.11 x 300
Ask1.20 x 200
Day's Range1.10 - 1.19
52wk Range0.90 - 1.87
1y Target EstN/A
Market Cap9M
P/E Ratio (ttm)-4.37
Beta0.01
Volume20,834
Avg Vol (3m)15,323
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire14 hours ago

    BASi Launches Embrace Automation Grant Program with Culex NxT™ Automated Blood Sampling System

    Bioanalytical Systems, Inc. , a recognized global leader in the development of instrumentation for automated blood sampling in animal models, is proud to announce its launch of the Embrace Automation grant program featuring the BASi Culex NxT ™ Automated Blood Sampling system and Raturn™.

  • Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2016 By the Numbers : August 15, 2016
    Capital Cube10 days ago

    Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2016 By the Numbers : August 15, 2016

    Categories: Yahoo Finance Get free summary analysis Bioanalytical Systems, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Bioanalytical Systems, Inc. – Quintiles Transnational Holdings, Inc., Charles River Laboratories International, Inc., PAREXEL International Corporation, Harvard Bioscience, Inc., Danaher Corporation, General Electric Company, SCYNEXIS, Inc., Thermo Fisher ... Read more (Read more...)

  • Business Wire15 days ago

    BASi Reports Third Quarter Results

    Bioanalytical Systems, Inc. today announced financial results for the third quarter and first nine months of fiscal 2016.